科学家们正在测试新的免疫重新规划疗法,这些疗法为肺炎和风湿性关节炎等自发免疫性疾病提供了潜在的治疗方法,超越了终生药物治疗。 Scientists are testing new immune-reprogramming therapies that offer potential cures for autoimmune diseases like lupus and rheumatoid arthritis, moving beyond lifelong medication.

科学家们正在开发突破性疗法,通过重新规划免疫系统而不是抑制免疫系统来治疗自发性免疫疾病。 Scientists are developing groundbreaking therapies to treat autoimmune diseases by reprogramming the immune system rather than suppressing it. 诸如CAR-T细胞疗法等实验治疗,为针对有害的B细胞重新设计T细胞,导致一些狼疮和风湿性关节炎患者的无毒品复发。 Experimental treatments like CAR-T cell therapy, which re-engineers T cells to target harmful B cells, have led to drug-free remission in some patients with lupus and rheumatoid arthritis. 研究人员还在探索监管T细胞、T细胞接触器和MRNA技术,以便精确重置免疫反应。 Researchers are also exploring regulatory T cells, T cell engagers, and mRNA technology to precisely reset immune responses. 这些方法虽然仍然费用高昂,而且仅限于先进的病例,但旨在长期缓解或治愈,标志着从终生医药向治疗性护理的潜在转变。 While still costly and limited to advanced cases, these approaches aim for long-term remission or cures, marking a potential shift from lifelong medication to curative care.